Cargando…
Central Nervous System Delivery of the Antipsychotic Olanzapine Induces Hepatic Insulin Resistance
OBJECTIVE: Olanzapine (OLZ) is an atypical antipsychotic whose clinical efficacy is hampered by side effects including weight gain and diabetes. Recent evidence shows that OLZ alters insulin sensitivity independent of changes in body weight and composition. The present study addresses whether OLZ-in...
Autores principales: | Martins, Paulo J.F., Haas, Michael, Obici, Silvana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3279549/ https://www.ncbi.nlm.nih.gov/pubmed/20682682 http://dx.doi.org/10.2337/db10-0449 |
Ejemplares similares
-
Stimulatory Effect of Insulin on Glucose Uptake by Muscle Involves the Central Nervous System in Insulin-Sensitive Mice
por: Coomans, Claudia P., et al.
Publicado: (2011) -
Pulsatile Portal Vein Insulin Delivery Enhances Hepatic Insulin Action and Signaling
por: Matveyenko, Aleksey V., et al.
Publicado: (2012) -
Acute Peripheral but Not Central Administration of Olanzapine Induces Hyperglycemia Associated with Hepatic and Extra-Hepatic Insulin Resistance
por: Girault, Elodie M., et al.
Publicado: (2012) -
Hypoglycemia associated with insulin hypersecretion following the addition of olanzapine to conventional antipsychotics
por: Nagamine, Takahiko
Publicado: (2006) -
Disruption of Adipose Rab10-Dependent Insulin Signaling Causes Hepatic Insulin Resistance
por: Vazirani, Reema P., et al.
Publicado: (2016)